mRNA Vaccines Market Size, Share & Industry Analysis, By Type (COVID-19 Vaccines and Non-COVID-19 Vaccines), By Indication (COVID-19 Infection, Respiratory Syncytial Virus (RSV) Infection, and Others), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI113546

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. New Product Launches, By Key Players
2. Pipeline Analysis, By Key Players
3. Technological Advancements in the mRNA Vaccines Market
4. Incidence/Prevalence of Key Diseases, 2024
5. Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)
Global mRNA Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. COVID-19 Vaccines
  2. Non-COVID-19 Vaccines
2. Market Analysis, Insights and Forecast – By Indication
  1. COVID-19 Infection
  2. Respiratory syncytial virus (RSV) Infection
  3. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America mRNA Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. COVID-19 Vaccines
  2. Non-COVID-19 Vaccines
2. Market Analysis, Insights and Forecast – By Indication
  1. COVID-19 Infection
  2. Respiratory syncytial virus (RSV) Infection
  3. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe mRNA Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. COVID-19 Vaccines
  2. Non-COVID-19 Vaccines
2. Market Analysis, Insights and Forecast – By Indication
  1. COVID-19 Infection
  2. Respiratory syncytial virus (RSV) Infection
  3. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific mRNA Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. COVID-19 Vaccines
  2. Non-COVID-19 Vaccines
2. Market Analysis, Insights and Forecast – By Indication
  1. COVID-19 Infection
  2. Respiratory syncytial virus (RSV) Infection
  3. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Rest of the World mRNA Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. COVID-19 Vaccines
  2. Non-COVID-19 Vaccines
2. Market Analysis, Insights and Forecast – By Indication
  1. COVID-19 Infection
  2. Respiratory syncytial virus (RSV) Infection
  3. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
  1. Moderna Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. BioNTech
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. CureVac SE
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. GSK plc
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Sanofi
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Pfizer Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Gennova Biopharmaceuticals Limited
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Walvax Biotechnology Co., Ltd.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Arcturus Therapeutics
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. New Product Launches, By Key Players
2. Pipeline Analysis, By Key Players
3. Technological Advancements in the mRNA Vaccines Market
4. Incidence/Prevalence of Key Diseases, 2024
5. Key Industry Developments (Mergers, Acquisitions, and Partnerships, etc.)
Global mRNA Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. COVID-19 Vaccines
  2. Non-COVID-19 Vaccines
2. Market Analysis, Insights and Forecast – By Indication
  1. COVID-19 Infection
  2. Respiratory syncytial virus (RSV) Infection
  3. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America mRNA Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. COVID-19 Vaccines
  2. Non-COVID-19 Vaccines
2. Market Analysis, Insights and Forecast – By Indication
  1. COVID-19 Infection
  2. Respiratory syncytial virus (RSV) Infection
  3. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe mRNA Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. COVID-19 Vaccines
  2. Non-COVID-19 Vaccines
2. Market Analysis, Insights and Forecast – By Indication
  1. COVID-19 Infection
  2. Respiratory syncytial virus (RSV) Infection
  3. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. U.K.
  2. Germany
  3. France
  4. Spain
  5. Italy
  6. Scandinavia
  7. Rest of Europe
Asia Pacific mRNA Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. COVID-19 Vaccines
  2. Non-COVID-19 Vaccines
2. Market Analysis, Insights and Forecast – By Indication
  1. COVID-19 Infection
  2. Respiratory syncytial virus (RSV) Infection
  3. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
4. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. Southeast Asia
  6. Rest of Asia Pacific
Rest of the World mRNA Vaccines Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. COVID-19 Vaccines
  2. Non-COVID-19 Vaccines
2. Market Analysis, Insights and Forecast – By Indication
  1. COVID-19 Infection
  2. Respiratory syncytial virus (RSV) Infection
  3. Others
3. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital & Retail Pharmacies
  2. Government Suppliers
  3. Others
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT analysis, Recent developments, strategies, financials (based on availability))
  1. Moderna Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. BioNTech
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. CureVac SE
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. GSK plc
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. Sanofi
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. Pfizer Inc.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Gennova Biopharmaceuticals Limited
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Walvax Biotechnology Co., Ltd.
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Arcturus Therapeutics
    1. Overview
    2. Products & services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 1: Global mRNA Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032

Figure 2: Global mRNA Vaccines Market Value Share (%), by Type, 2024 & 2032

Figure 3: Global mRNA Vaccines Market Value Share (%), by Indication, 2024 & 2032

Figure 4: Global mRNA Vaccines Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 5: Global mRNA Vaccines Market Value Share (%), by Region, 2024 & 2032

Figure 6: North America mRNA Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 7: North America mRNA Vaccines Market Value Share (%), by Type, 2024

Figure 8: North America mRNA Vaccines Market Value (USD billion), by Indication, 2024 & 2032

Figure 9: North America mRNA Vaccines Market Value Share (%), by Indication, 2024

Figure 10: North America mRNA Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 11: North America mRNA Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 12: North America mRNA Vaccines Market Value (USD billion), By Country, 2024 & 2032

Figure 13: North America mRNA Vaccines Market Value Share (%), By Country, 2024

Figure 14: Europe mRNA Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 15: Europe mRNA Vaccines Market Value Share (%), by Type, 2024

Figure 16: Europe mRNA Vaccines Market Value (USD billion), by Indication, 2024 & 2032

Figure 17: Europe mRNA Vaccines Market Value Share (%), by Indication, 2024

Figure 18: Europe mRNA Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 19: Europe mRNA Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 20: Europe mRNA Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 21: Europe mRNA Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 22: Asia Pacific mRNA Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 23: Asia Pacific mRNA Vaccines Market Value Share (%), by Type, 2024

Figure 24: Asia Pacific mRNA Vaccines Market Value (USD billion), by Indication, 2024 & 2032

Figure 25: Asia Pacific mRNA Vaccines Market Value Share (%), by Indication, 2024

Figure 26: Asia Pacific mRNA Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 27: Asia Pacific mRNA Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 28: Asia Pacific mRNA Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032

Figure 29: Asia Pacific mRNA Vaccines Market Value Share (%), By Country/ Sub-region, 2024

Figure 30: Rest of the World mRNA Vaccines Market Value (USD billion), by Type, 2024 & 2032

Figure 31: Rest of the World mRNA Vaccines Market Value Share (%), by Type, 2024

Figure 32: Rest of the World mRNA Vaccines Market Value (USD billion), by Indication, 2024 & 2032

Figure 33: Rest of the World mRNA Vaccines Market Value Share (%), by Indication, 2024

Figure 34: Rest of the World mRNA Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032

Figure 35: Rest of the World mRNA Vaccines Market Value Share (%), by Distribution Channel, 2024

Figure 36: Global mRNA Vaccines Market Share (%), By Company, 2024

List of Tables

Table 1: Global mRNA Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 2: Global mRNA Vaccines Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 3: Global mRNA Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 4: Global mRNA Vaccines Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 5: North America mRNA Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 6: North America mRNA Vaccines Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 7: North America mRNA Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 8: North America mRNA Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 9: Europe mRNA Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 10: Europe mRNA Vaccines Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 11: Europe mRNA Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 12: Europe mRNA Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 13: Asia Pacific mRNA Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 14: Asia Pacific mRNA Vaccines Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 15: Asia Pacific mRNA Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 16: Asia Pacific mRNA Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 17: Rest of the World mRNA Vaccines Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 18: Rest of the World mRNA Vaccines Market Revenue (USD billion) Forecast, by Indication, 2019–2032

Table 19: Rest of the World mRNA Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032a

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 160

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com